Document is current
Any future updates will be listed below
-
Authors
Dezoumbe, Koutaya
Djarma, Oumaima
Wondeu, Andrillene Laure Deutou
Zakaria, Fatima Abdelrazak
Atturo, Sabrina
Naïbeï, Nathan
Mennechet, Franck J. D.
Campagna, Denise
Boukar, Abdoulaye
Moussa, Choroma Ahmat
Mahamat, Issa
Armand, Nontegyol
Hamad, Mahamat Idriss
Honorine, Netalar
Frederic, Kayanlengar
Moustapha, Adam Adami
Daniel, Yanda Mberkissam
Alim, Adam Moussa
Grene, Mahamat
Suitombaye, Noubaramadji Yamti
Akouya, Amine
Choua, Ouchemi
Mathieu, Hota
Djimtoïbaye, Djallaye
Colizzi, Vittorio
Cappelli, Giulia
Rodrigue, Takoudjou Dzomo Guy
Abakar, Mahamat Fayiz
Moussa, Ali Mahamat
- License Information
-
More Information
Article History
Received: 9 February 2024
Accepted: 18 October 2024
First Online: 11 November 2024
Declarations
:
: The study protocol was approved by the Chad National Bioethics Committee (CNBT) on 08 April 2022 under number: 011CMT/PC/PMT/MESRI/SG/CNBT/2022 and authorized by the Chad Ministry of Public Health under number: N°2326/CMT/PC/PMT/MSPSN/SE/SG/DGPC/DPERO/SRO/2022. The protocol was presented to 11 focal points including 10 provinces and N’Djamena selected for the study. Training sessions on the data collection tool were organized before the start of data and sample collection. An information sheet was given to each voluntary participant as well as the signature of informed consent and assent for minors. The informed consent was obtained from all participants involved. For adult participants (aged ≥ 16 years), informed consent was obtained directly from each individual. For minor participants (aged < 16 years), informed consent was obtained from parents or the legally authorized representative (LAR). In both cases, consent was obtained in accordance with the ethical guidelines established by the approving ethics committee. Each participant was assigned a unique code, and the data was handled confidentially.
: Not applicable.
: The authors declare no competing interests.
